Clik here to view.
ChromaDex Finalizes Commercial Joint-Venture in Asia and Announces $3.1...
LOS ANGELES ChromaDex Corp. (NASDAQ:CDXC) (the “Company”), a global bioscience company dedicated to healthy aging, today announced that it has established a joint venture through its wholly owned...
View ArticleClik here to view.
Biospectal Partners with Amref Health Africa to Extend Global Access to Blood...
LAUSANNE, Switzerland Biospectal SA, the remote patient monitoring and biosensing software company, and Amref Health Africa, the largest health NGO in Africa, today announced the launch of a Mobile...
View ArticleClik here to view.
“Our Rights, Our Future,” says AHF on International Day of the Girl Child!
LOS ANGELES International Day of the Girl Child (IDGC) 2022 has arrived! AIDS Healthcare Foundation (AHF) will hold “Our Rights, Our Future”-themed events worldwide that will educate and empower...
View ArticleClik here to view.
World Economic Forum Recognises Dr. Reddy’s Hyderabad Factory as Part of its...
HYDERABAD, India & PRINCETON, N.J. Dr. Reddy’s Laboratories Ltd. (BSE: 500124, NSE: DRREDDY, NYSE: RDY, NSEIFSC: DRREDDY; hereafter referred to as “Dr. Reddy’s”), a global pharmaceutical...
View ArticleClik here to view.
DNA Script Extends Distributorships to Middle East to Expand Access to...
SOUTH SAN FRANCISCO, Calif. & PARIS DNA Script, a world leader in Enzymatic DNA Synthesis (EDS) for DNA on demand, has signed distribution agreements in the Middle East with Gulf Scientific...
View ArticleClik here to view.
Medtech Startup NousQ Receives US$175K Grand Prize for Pediatric Ear Tube...
LOS ANGELES & SINGAPORE MedTech Innovator, the largest accelerator of medical devices in the world, in partnership with Asia Pacific Medical Technology Association (APACMed), the first and only...
View ArticleClik here to view.
Clik here to view.
Sermo调查：全球87%的医生认为缺乏治疗新冠长期症状的临床指南
纽约 (美国商业资讯)–Sermo是一个医生优先的在线社区和全球医疗保健提供者洞察力的领导者。该组织的一项新调查发现，大多数医生认为在他们的实践中缺乏诊断和治疗新冠长期症状的临床指南。这项对全球1,100多名医生的调查发现，86%的医生认为缺乏如何诊断新冠长期症状的临床指导。87%的医生认为目前缺乏如何治疗新冠长期症状患者的临床指导。 长期症状是医生和患者关注的首要问题：...
View ArticleClik here to view.
2022 CHUNGBUK BEST PRODUCT PROMOTION Opens in Malaysia to Develop Market for...
CHEONGJU, South Korea & KUALA LUMPUR, Malaysia Chungcheongbuk-do has started to secure export channels for promising exporters in North Chungcheong Province to the Malaysian market. The 2022...
View ArticleClik here to view.
Bio-Thera Solutions Announces First Patient Dosed in Phase 1 Study for...
GUANGZHOU, China Bio-Thera Solutions, Ltd. (SH: 688177), a commercial-stage biopharmaceutical company, today announced that dosing has begun in a Phase I clinical study to compare the...
View ArticleClik here to view.
Takeda Receives Positive CHMP Opinion Recommending Approval of Dengue Vaccine...
OSAKA, Japan & CAMBRIDGE, Mass. Takeda (TSE:4502/NYSE:TAK) today announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) recommended the...
View ArticleClik here to view.
Clik here to view.
当人类破解量子计算后，治疗癌症将像治疗普通感冒一样容易
阿联酋迪拜 (美国商业资讯)–量子计算方面的突破将使人类能够像治疗普通感冒一样轻松治愈癌症、阿尔茨海默病和帕金森病等疾病。 本新闻稿包含多媒体。此处查看新闻稿全文： https://www.businesswire.com/news/home/20221014005369/zh-CN/ One of the sessions that took place at Dubai Future...
View ArticleClik here to view.
Single Use Support Launches IRIS Single-Use Bag Line
KUFSTEIN, Austria Austrian solution provider Single Use Support GmbH is expanding its product portfolio with new single-use bioprocess containers under the brand name IRIS. The pioneering company...
View ArticleClik here to view.
武田薬品、EUおよびデング熱流行国におけるデング熱ワクチン候補の承認推奨に関するCHMPの肯定的見解を受領
大阪 & 米マサチューセッツ州ケンブリッジ （ビジネスワイヤ） —...
View ArticleClik here to view.
Teijin Automotive Technologies’ Teams Get Creative for a Cause
AUBURN HILLS, Mich. When the Operations and Health and Safety management teams of Teijin Automotive Technologies gathered in San Antonio, Texas, earlier this month, operational improvement was not...
View ArticleClik here to view.
百奥赛图全资子公司祐和医药与美国Syncromune公司就OX40单抗（YH002）等达成全球授权协议，共同开发瘤内免疫疗法
中国北京与美国罗德岱堡 (美国商业资讯) — 百奥赛图（北京）医药科技股份有限公司（“百奥赛图”）的全资子公司祐和医药科技（北京）有限公司（“祐和医药”）今日宣布与临床阶段的美国生物制药公司Syncromune达成协议，共同开发和商业化基于Syncrovax™技术的瘤内免疫疗法。...
View ArticleClik here to view.
Eucure Biopharma, a Subsidiary of Biocytogen Pharmaceuticals, Licenses OX40...
BEIJING, China & FORT LAUDERDALE, Fla. Eucure (Beijing) Biopharma Co., Ltd. (“Eucure”), a wholly owned subsidiary of Biocytogen Pharmaceuticals (Beijing) Co., Ltd. (“Biocytogen”), announced...
View ArticleClik here to view.
Clik here to view.
Eucure Biopharma, a Subsidiary of Biocytogen Pharmaceuticals, Licenses OX40...
BEIJING & FORT LAUDERDALE, Fla. Eucure (Beijing) Biopharma Co., Ltd. (“Eucure”), a wholly owned subsidiary of Biocytogen Pharmaceuticals (Beijing) Co., Ltd. (“Biocytogen”), announced today that...
View Article